Verbatim response from Claude
Wegovy vs Zepbound: Quick Comparison
The Drugs
Wegovy (semaglutide)
- GLP-1 receptor agonist
- Made by Novo Nordisk
- FDA-approved for weight loss
- Typical weight loss: ~15% body weight
Zepbound (tirzepatide)
- Dual GIP/GLP-1 receptor agonist
- Made by Eli Lilly
- FDA-approved for weight loss
- Typical weight loss: ~20-22% body weight
Which to Ask For?
Zepbound generally wins on effectiveness based on clinical trial data (SURMOUNT vs STEP trials). If maximum weight loss is your goal, most evidence favors Zepbound.
Consider Wegovy if:
- You have cardiovascular disease history (stronger CV outcome data)
- Your insurance covers it but not Zepbound
- You've responded well to semaglutide before
Where to Get Either Online
- Hims/Hers – offers telehealth prescriptions
- WeightWatchers Clinic – includes coaching
- Ro Body – straightforward telehealth platform
- Found – includes behavioral support
- Your insurance's preferred telehealth provider
Important Notes
- You need a prescription from a licensed provider
- Costs vary significantly by insurance
- Watch out for compounded versions – quality varies
Would you like more detail on any specific aspect?